March 6, 2019
Recently diabetes management has focused on making sure we are using medications that reduce the leading cause of death in diabetes: cardiovascular disease. Come learn about these medications from WSU graduate Mark Fillcetti.
Type II diabetes and cardiovascular outcomes
Speaker: Mark Fillcetti, RPh
Lead Clinical Research Pharmacist, St. Luke’s Health System, Boise, ID
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
& Lilly USA, LLC
No CE is offered for this event.
Pharmacists, technicians and student pharmacists are welcome.
Wednesday, March 6 2019
1005 W 1st Ave
Spokane, WA 99201
This event is free, but you must RSVP by Monday, March 4, 2019.
Registration for this event is now closed.
This program is open to healthcare practitioners (HCPs) for whom the information presented is relevant to their practice. Spouses or guests cannot be accommodated.
BIPI and Lilly USA, LLC have adopted the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals that went into effect on July 1, 2002. Pursuant to the Code, inclusion of healthcare professionals’ spouses or guests is not permitted. We appreciate your understanding and support of our commitment to following the highest ethical standards as related to interactions with healthcare professionals. To comply with federal regulations, attendance at the entire session is required and early departures are not permitted.